Your AccountResearch, Evidence & Learning
Impact of Multiple Sclerosis Symptoms (IMSS)
You can find all the project information and brochures for each country here.
MS specialist perspective – European Parliament debate on Real World Data
Prof. Eva Havrdova talked about the potential of real world data to drive regulatory and reimbursement decisions at EMSP’s related…
Press Release: Real World Evidence data, key to equitable health care systems?
People living with MS in Europe could receive timelier access to safer and more efficient therapies. The key is better exploitation of…
Patient perspective – European Parliament debate on Real World Data
Patient advocate Francois Houyez of EURORDIS talked about the patient benefits from the use real world data at EMSP’s related European…
MCB: Setting up MS Registries with MS Societies in the Western European region
The Workshop on Setting up MS Registries with Multiple Sclerosis Societies in the Western European region, part of EMSP’s Membership…
MCB: MS Registries with MS Societies in the Balkans region
The Workshop on MS Registries with MS Societies in the Balkans regional, part of EMSP’s Membership Capacity Building Programme, was…
EMA regulatory perspective – European Parliament debate on Real World Data
In this resource, we explore the European Medicines Agency’s (EMA) regulatory perspective on the use of real‑world data (RWD), as…
